COPYRIGHT© Jilin Zixin Pharmaceutical Industrial Co.,Ltd.

COPYRIGHT© 2018  吉林紫鑫药业股份有限公司

Jilin Zixin Chuyuan Pharmaceutical successfully passed the QS renewal audit

Page view

On August 18, 2015, a 40-member delegation led by Cheng Peng, the chairman of the Beijing Second Business Group Labor Union, visited Jilin Zixin Chuyuan Pharmaceutical Co., Ltd., and Han Xu, deputy general manager of the company's quality department, received the reception.

 

Beijing Ershang Group is a large-scale food industry group supported by food manufacturing, modern logistics, modern distribution and professional markets, and supported by food technology, education, information and property management. It mainly produces and sells more than 20,000 kinds of commodities in more than 20 categories including pork, beef and mutton, seafood and aquatic products and products, and sugar, wine, tobacco, tea, condiments, cakes, vegetables, tofu and its products, and commercial low-temperature equipment. The Group has established a high standard food quality and safety assurance system throughout the food production and operation process, forming a complete food industry chain from the field to the table, realizing traceable source, traceable flow, process control, and product recallable safe food. management. The second business group is affiliated to the Beijing State-owned Assets Supervision and Administration Commission. The Group undertakes the food supply tasks of important meetings and major events held by the party and the state in Beijing, and undertakes the reserve tasks of important foods of the central and Beijing governments. It plays an important role in regulating the market, responding to emergency disasters, and ensuring social stability. effect.

 

After visiting the Jilin Zixin Chuyuan Company's factory area, the delegation of the quality department, Han Xu, introduced the basic situation of Chuanyuan Pharmaceutical to the chairman of the Beijing Second Business Group Labor Union. Han Xu said that Jilin Zixin Chuyuan Pharmaceutical Co., Ltd. is a wholly-owned subsidiary of Jilin Zixin Pharmaceutical Co., Ltd., a large-scale pharmaceutical listed company. The company was established in June 2010 and covers an area of ​​96,000 square meters. 46,000 square meters, construction area of ​​30,000 square meters, investment of 375 million yuan. The company is mainly engaged in the intensive processing of ginseng serialized edible health care products. The core production technology is based on the extraction and pure extraction of polysaccharides, peptides, rare saponins, total saponins and monomeric saponins of ginseng. The company takes ginseng fruit and vegetable enzyme beverage, jade red and red ginseng gelatin cake, fresh ginseng honey tablets, ginseng ginseng binaural beverage, ginseng ginseng beverage, wild ginseng broken wall powder and other ginseng finishing products as the core competitive products. The first processed products are Linxia ginseng powder, garden ginseng powder, American ginseng powder, Linxia ginseng, wild ginseng, fine red ginseng, fine raw ginseng, raw sun ginseng, red ginseng, western ginseng, raw ginseng, red The ginseng and ginseng flowers are the main products.

 

Subsequently, Jilin Zixin Chuyuan Company and Ershang Group held talks on cooperation intentions. Chairman Cheng Peng gave a detailed introduction to the development history, enterprise positioning, product and sales situation, and future planning of the Second Business Group. He highly praised the achievements of Chuanyuan Company relying on the ginseng deep processing industry. The two sides conducted in-depth communication and discussion on food safety control, the protection of farmers' interests, the development trend of ginseng industry and strategic cooperation, which laid the foundation for the next step of cooperation.

 

Both parties stated that in the current environment of China's economic development, cooperation between enterprises is very necessary. Cooperation can not only achieve mutual benefit, but also effectively improve the market competitiveness of enterprises. First of all, enterprises must develop toward high precision and large-scale, and the demand for various production processes and equipment will continue to increase. Secondly, domestic pharmaceutical and food and beverage companies are developing in a personalized and diversified manner. Consumers also have high requirements for the types and appearance of products. Therefore, the development of information technology, the collaborative research and development of new products, and the sharing of human resources become very necessary. In order to strengthen the competitiveness of enterprises in international trade and regional trade, a complete system from rough processing to finishing, quality control and monitoring should be established to promote the long-term effective development of both enterprises.

 

The two sides stated that the pharmaceutical and food and beverage industries should vigorously develop advanced science and technology, broaden the scope of application of technology, and transform advanced science and technology and advanced processes into productivity in a timely manner to meet China's growing large-scale and demanding needs. market. In order to take the intensive development path, the high-end production equipment and technology are the only way for the industry to seek new development. It has become a hard demand for enterprises to accelerate the pace of cooperation on the existing basis to adapt to the increasingly fierce market competition.

 

"Sea memory confidant, the end of the world if you are next to each other." In the principle of mutual benefit and common development, Zixin Pharmaceutical will carry out more extensive, deeper and more effective cooperation with more related companies, work together and complement each other. Collusion and win-win situation!